Liver mass historical perspective

Jump to: navigation, search

Liver Mass Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differential Diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Evaluation of Liver Mass

Staging

History and Symptoms

Physical Examination

Laboratory Studies

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Liver mass historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Liver mass historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Liver mass historical perspective

CDC on Liver mass historical perspective

Liver mass historical perspective in the news

Blogs on Liver mass historical perspective

Directions to Hospitals Treating bone or soft tissue mass

Risk calculators and risk factors for Liver mass historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Liver mass as a separate entity was first described in detail by Hippocrates. He was also the first to differentiate liver abscess from other liver masses. In 1843, Dr. Robert Liston, a British surgeon, was the first to describe hemangioma. In 1911, Yamagiwa suggested a new classification system based on the cell of origin and divided hepatobiliary cancers into hepatocellular cancer and cholangiocellular cancer, with the proposed terminology of hepatoma and cholangioma. In 1958, I Bartok discovered hepatoblastoma for the first time.

Historical Perspective

References

  1. Liston R (1843). "Case of erectile tumour in the popliteal space.-Removal". Med Chir Trans. 26: 120–32. PMC 2116921. PMID 20895766.
  2. Yamagiwa K. Zum Kenntniss des prim%ren parenchymatosen Leberkarzinoms (“Hepatoma”). Virchows Arch Path Anat 1911;203:75-131.
  3. Okuda K (2002). "Hepatocellular carcinoma--history, current status and perspectives". Dig Liver Dis. 34 (9): 613–6. PMID 12405244.
  4. Madabhavi, Irappa; Patel, Apurva; Choudhary, Mukesh; Aagre, Suhas; Revannasiddaiah, Swaroop; Modi, Gaurang; Anand, Asha; Panchal, Harsha; Parikh, Sonia; Raut, Shreeniwas (2014). "Paraneoplastic Recurrent Hypoglycaemic Seizures: An Initial Presentation of Hepatoblastoma in an Adolescent Male—A Rare Entity". Case Reports in Pediatrics. 2014: 1–5. doi:10.1155/2014/104543. ISSN 2090-6803.
  5. Barthelmes L, Tait IS (2005). "Liver cell adenoma and liver cell adenomatosis". HPB (Oxford). 7 (3): 186–96. doi:10.1080/13651820510028954. PMC 2023950. PMID 18333188.
  6. Baum JK, Bookstein JJ, Holtz F, Klein EW (1973). "Possible association between benign hepatomas and oral contraceptives". Lancet. 2 (7835): 926–9. PMID 4126557.

Linked-in.jpg